SEC Tracker
Get the app

Interpace Biosciences IDXG

Interpace Biosciences Announces CFO Leadership Transition

Form
8-K
Filed
Importance
Routine
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Interpace Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (3841) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Global Innovative Platforms GIPL public float $3M, Sep 30, 2025
  2. Bluejay Diagnostics BJDX public float $3M, Jun 30, 2025
  3. Stimcell Energetics STME public float $2M, Nov 30, 2025
  4. INVO Fertility IVF public float $2M, Jun 30, 2025
  5. Nu-Med Plus NUMD public float $3M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.